新日本製薬
4931
東証プライム
化学
新日本製薬の決算推移
損益計算書
(単位:百万円)
2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
---|---|---|---|---|---|---|
売上高 | 33,570 | 33,728 | 33,899 | 36,107 | 37,653 | 40,043 |
売上原価 | 4,887 | 5,110 | 5,439 | 6,711 | 7,341 | 8,230 |
売上総利益 | 28,682 | 28,617 | 28,460 | 29,395 | 30,312 | 31,812 |
販管費 | 25,809 | 25,293 | 25,032 | 25,872 | 26,557 | 27,635 |
営業利益 | 2,864 | 3,329 | 3,424 | 3,522 | 3,754 | 4,176 |
営業外収益 | 30 | 51 | 75 | 56 | 45 | 110 |
営業外費用 | 66 | 85 | 85 | 91 | 78 | 184 |
経常利益 | 2,828 | 3,295 | 3,414 | 3,487 | 3,721 | 4,103 |
特別利益 | N/A | N/A | N/A | 3 | N/A | 6 |
特別損失 | 6 | 115 | 12 | 15 | 191 | N/A |
当期純利益 | 1,824 | 2,122 | 2,317 | 2,357 | 2,394 | 2,795 |
貸借対照表
(単位:百万円)
2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
---|---|---|---|---|---|---|
資産 | 18,575 | 19,956 | 23,197 | 23,857 | 25,501 | 27,222 |
流動資産 | 14,693 | 16,211 | 18,528 | 19,265 | 21,254 | 23,062 |
現金及び預金 | 10,576 | 12,271 | 13,652 | 14,351 | 15,518 | 16,341 |
売上債権 | 2,913 | 2,607 | 3,196 | 2,862 | 3,171 | 4,291 |
棚卸資産 | 1,062 | 1,193 | 1,404 | 1,735 | 2,091 | 2,028 |
固定資産 | 3,882 | 3,744 | 4,669 | 4,592 | 4,247 | 4,160 |
負債 | 5,817 | 5,688 | 7,023 | 5,938 | 5,840 | 5,430 |
流動負債 | 4,544 | 4,474 | 4,712 | 3,975 | 5,083 | 4,873 |
仕入債務 | 416 | 509 | 527 | 553 | 946 | 548 |
固定負債 | 1,272 | 1,214 | 2,311 | 1,963 | 757 | 556 |
純資産 | 12,758 | 14,267 | 16,174 | 17,918 | 19,661 | 21,792 |
利益剰余金 | 5,113 | 6,857 | 8,532 | 10,199 | 11,885 | 13,971 |
自己株式 | N/A | -299 | -852 | -735 | -647 | -529 |